key: cord-0960616-lfb2n6zk authors: Barreiro‐de Acosta, Manuel; Gutiérrez, Ana; Zabana, Yamile; Beltrán, Belén; Calvet, Xavier; Chaparro, María; Domènech, Eugeni; Esteve, Maria; Panés, Julian; Gisbert, Javier P.; Nos, Pilar title: Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience date: 2021-06-05 journal: United European Gastroenterol J DOI: 10.1002/ueg2.12105 sha: 9abf1443118f4418927b3211064817ca4bd32dcb doc_id: 960616 cord_uid: lfb2n6zk BACKGROUND: One of the most valued targets in inflammatory bowel disease (IBD) is for physicians to provide and patients to receive a high‐level quality of care. This study aimed to evaluate the implementation of a nationwide quality certification programme for IBD units. METHODS: Identification of quality indicators (QI) for IBD Unit certification was based on Delphi methodology that selected 53 QI, which were subjected to a normalisation process. Selected QI were then used in the certification process. Coordinated by GETECCU, this process began with a consulting round and an audit drill followed by a formal audit carried out by an independent certifying agency. This audit involved the scrutiny of the selected QI in medical records. If 80%–90% compliance was achieved, the IBD unit audited received the qualification of “advanced”, and if it exceeded 90% the rating was “excellence”. Afterwards, an anonymous survey was conducted among certified units to assess satisfaction with the programme for IBD units. RESULTS: As of January 2021, 66 IBD units adhere to the nationwide certification programme. Among the 53 units already audited by January 2021, 31 achieved the certification of excellence, 20 the advanced certification, and two did not obtain the certification. The main survey results indicated high satisfaction with an average score of 8.5 out of 10. CONCLUSION: Certification of inflammatory bowel disease units by GETECCU is the largest nationwide certification programme for IBD units reported. More than 90% of IBD units adhered to the programme achieved the certification. The project was one of the strategic lines of GETECCU and discussed by the committee that designed that project. It was presented to all GETECCU members in order to subscribe to it. IBD units voluntarily applied for certification. Once an IBD unit applied, an initial visit to the centre was performed to ascertain the level of compliance with all the indicators and establish an action plan. Once a unit considered it was ready for the audit, a mock audit supported by GETECCU was carried out within approximately 5 months from the first visit. An independent auditor performed the mock audit. After the mock audit, a confidential report was sent by the same independent auditor to the IBD unit to find out if they are now ready for the official audit. Two months later, an official audit was carried out by an external independent agency called Bureau Veritas, a global leader company in inspection, audits, and certification for over 30 years (https://www. bureauveritas.es). The final audit consisted of a 2-day visit to the unit with an exhaustive review of all selected indicators. This audit included the evaluation of the structure of the institution (gastroenterology, surgery, endoscopy, and radiology departments), the review of all protocols, and the assessment of their compliance through the review of medical records. It also included an interview with all the members of the multidisciplinary team, including nurses and surgeons, a review of their curriculum vitae, and, finally, a detailed random evaluation of 40 medical records of different clinical scenarios (patients in remission, mild or severely active disease, postsurgical setting, hospitalised, pregnant, under cancer surveillance programme, etc.). If a centre has a referral surgery hospital and has an official agreement with that hospital and it is verified in the medical records that all surgical patients are systematically sent to referral, the standard is considered to be correct. The condition must be that the referral centre has previously demonstrated certification. Summarise the established knowledge on this subject � One of the most highly valued targets in IBD treatment is to achieve a high-level quality of care � IBD units are the best way to provide this high-level quality of care What are the significant and/or new findings of this study? � CUE is the largest nationwide certification programme for IBD units reported to date. � Certification by an independent agency gives added value to the programme. � More than 90% of IBD units that adhered to the programme achieved the certification. After the audit, the independent auditor emitted a verdict with a detailed report, including the degree of compliance with the QI. If compliance exceeded 90%, the unit was given the rating "excellence", and the unit has to be re-certified in 3 years. If 80%-90% compliance was achieved, the Unit was qualified as "advanced", and must be re-certified in 2 years. In those cases with less than 80% compliance, the unit was not awarded the certification, but GETECCU compromised to help the IBD unit with an action plan to improve the missing indicators. The unit was allowed to apply again for the certification after a minimum sixmonth period. Finally, an official act of certification delivery was held in which regional health system managers, hospital directives, and patients' associations (called ACCU in Spain, https://accuesp.com) were invited. There was coverage of the delivery act by both local and national media. Figure 1 shows the flowchart of the process. The number and percentage of IBD units that achieved certification practice audit). Most of these units applied to the CUE programme during the COVID-19 pandemic, and it is expected that they will be audited within the following months. Detailed evaluation of the 53 selected QI showed that 40 QI were achieved in more than 90% of the units. There were two QI that were reached by less than 50% of the units; one was related to the written report of the information given to the patients about the potential risks of biological and immunosuppressant drugs in the clinical records, and the other was related to the performance of at least 10 ileoanal pouch surgeries within the previous year. The percentage of QI achieved per each question is shown in Table S1 . The first 40 IBD units audited answered a questionnaire to evaluate the perceptions on and the satisfaction with the CUE programme. The results are shown in Table 1 . The results showed a high satisfaction rate with the CUE programme, with an average score of 8.5, out of 10; scores were over eight in all questions. Regarding the open questions concerning future issues for the improvement of the programme, the more demanded ones were to give more weight to paediatric transition and nutritional support for patients. Since the start of the CUE programme, every time an IBD unit achieved the certification, an official act of certification delivery was held, and a press release was written and sent to the local and national media. Their main messages were about the importance of early diagnostic and treatment of IBD, the role of multidisciplinary teams, the need for monitorisation, and the relevance of quality of care in IBD. At the end of 2020, the total number of impacts in the media amounted to 437. Of them, 36% were published in specialised health media and 64% in general media (42% national and 58% local). To the best of our knowledge, this is the largest nationwide study to date which provides evidence on the possibility of implementation of a certification programme for IBD units. With our results, based on more than 50 IBD units certified all over the country, almost 40% of the Spanish population can be attended with certified quality care in IBD. Further development of the programme has the potential to enable many Spanish IBD patients to be cared for in a certified IBD unit. This is likely to improve the overall quality of care for IBD patients. One of the most valued targets in IBD treatment is for physicians to provide and patients to receive a high-level quality of care. 9 Nevertheless, this is not easy to achieve, especially in a nationwide Patients treated by gastroenterologists from academic centres were also more likely to be in remission, receive the flu vaccine, and have better quality of life. 10 In a retrospective propensity-matched scored study performed in a Canadian centre, the authors compared the quality of care in IBD before and after implementing an integrated Has the certification process of my IBD unit contributed or will contribute to standardize the care of my patients? Several other studies have identified variation in levels of care, and, against this background, a certification of IBD units could be a path for improving standards of care in IBD. 13, 14 The best way to measure quality of care in IBD is by using QI. In response to the variation in care between practitioners, QI have been developed in both the United States 15 and Canada 16 for IBD management, with 11 QI in each case. We used the GETECCU QI for the certification programme, which consists of 53 QI based on Delphi methodology and which were further validated in our country by patients and nurses. 6 Recently ECCO published their own 90 quality of care standards in IBD, with a high concordance with GETECCU's QI, 17 which supports the current validity of our QI. However, due to the rapid changes in IBD management, GETECCU is currently working on and updating the QI. Some programmes in the United States audited IBD clinical practices to determine the quality of care, but their results mainly addressed private practice and reimbursement. 10 Prospective data is aggregated in a central database and used to generate weekly audit and feedback reports for the participating centres. These reports are reviewed by the sites, and modifications are made to processes to improve outcomes. Involvement in this programme resulted in an increase in remission rates from 55% to 75% over the past few years. 15, 18 A well-designed nationwide study evaluating the quality of care in IBD has been performed in New Zealand. The programme consisted of three phases, the third being an audit of key aspects of IBD care. However, the audit, which was performed in 14 centres in contrast to ours, was more focused on validating the role of nursing than evaluating the global aspects of an IBD unit. 19 25 We hope that giving a higher impact of the disease in the media and showing the importance of IBD units for society will help attract future IBD stakeholders. There are, however, various limitations in our programme. First, adherence to the programme is voluntary. Furthermore, the results obtained in the satisfaction questionnaire could be biased, because they were answered just after certification, this being a moment of great optimism in the unit. Finally, our results could be difficult to extrapolate to other countries with different or more private healthcare systems due to Spain's predominantly public health care system. On the other hand, our study has several strengths. The main one is the external evaluation by an independent agency specialised in certification. The quality of the certification programme is based on QI that have been designed with Delphi methodology and previously published by our Medical Society. 6 Another strength is the homogeneity of the programme all over our country, which is an opportunity for a patient with IBD located anywhere in the national territory to be treated with the same quality standards. In conclusion, CUE is the largest nationwide certification programme for IBD units reported to date. More than 90% of IBD units that adhered to the programme achieved the certification. The support of patient associations and managers is essential for giving value to this type of project. This programme has increased IBD and GETECCU visibility in our country. This is probably the first step towards homogenising IBD assistance all over the country. AbbVie sponsored the CUE programme. AbbVie had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain Time trends of Crohn's disease in Catalonia from 2011 to 2017. Increasing use of biologics correlates with a reduced need for surgery The burden of cost in inflammatory bowel disease: a medical economic perspective Optimising the inflammatory bowel disease unit to improve quality of care: expert recommendations N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis Delphi consensus statement: quality indicators for inflammatory bowel disease comprehensive care units European Stroke Organisation certification of stroke units and stroke centres Poor documentation of inflammatory bowel disease quality measures in academic, community, and private practice Quality of care in inflammatory bowel diseases: what is the best way to better outcomes? Variation in care of inflammatory bowel diseases patients in Crohn's and Colitis Foundation of America partners: role of gastroenterologist practice setting in disease outcomes and quality process measures Impact of an integrated model of care on outcomes of patients with inflammatory bowel diseases: evidence from a population-based study IBD and health-related quality of life --discovering the true impact Clinicians' adherence to international guidelines in the clinical care of adults with inflammatory bowel disease Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States Quality indicators for inflammatory bowel disease: development of process and outcome measures Defining quality indicators for best-practice management of inflammatory bowel disease in Canada Quality of care standards in inflammatory bowel diseases: a European Crohn's and Colitis Organisation [ECCO] position paper Approaches to improve quality of care in inflammatory bowel diseases New Zealand National Audit of outpatient inflammatory bowel disease standards of care Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia Improving the quality of care for people with inflammatory bowel disease (IBD): results of a national audit Inflammatory bowel disease in the UK: is quality of care improving? Excellence centers in inflammatory bowel disease in Romania: a measure of the quality of care Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising The cost of inflammatory bowel disease: an initiative from the Crohn's & Colitis Foundation Inflammatory bowel disease integral care units: evaluation of a nationwide quality certification programme. The GETECCU experience. United Javier Santiago, Jesús Martín, Bureau Veritas, patient's associations (ACCU), and all IBD units adhered to the programme.